Abstract
Up to 20% of the patients who undergo radical surgery for colorectal cancer experience recurrence. Hyperthermic intraperitoneal chemotherapy (HIPEC) and cytoreductive surgery have shown to be effective treatment of peritoneal carcinomatosis. HIPEC administered at the primary operation in high-risk patients may also be effective in preventing peritoneal carcinomatosis and improve survival in patients with advanced gastrointestinal cancer.
| Translated title of the contribution | Hyperthermic intraperitoneal chemotherapy at the primary gastrointestinal cancer operation |
|---|---|
| Original language | Danish |
| Journal | Ugeskrift for Laeger |
| Volume | 179 |
| Issue number | 12 |
| Pages (from-to) | V06160454 |
| ISSN | 0041-5782 |
| Publication status | Published - 20 Mar 2017 |
Keywords
- English Abstract
- Journal Article
Fingerprint
Dive into the research topics of 'Hyperthermic intraperitoneal chemotherapy at the primary gastrointestinal cancer operation'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS